TWINNING FOR A EUROPEAN CONSORTIUM OF RECTAL CANCER RESEARCH INSTITUTIONS THROUGH STEPPING UP SCIENTIFIC, TECHNOLOGICAL AND INNOVATION EXCELLENCE OF IORS

Información del proyecto

STEPUPIORS

Identificador del acuerdo de subvención: 101079217

DOI

10.3030/101079217

Proyecto cerrado

Fecha de la firma de la CE 14 Julio 2022

Fecha de inicio 1 Octubre 2022

Fecha de finalización 30 Septiembre 2025

Financiado con arreglo a

• Widening participation and spreading excellence

Coste total

€ 1 500 000,00

Aportación de la UE

€ 1 500 000,00

Coordinado por

INSTITUT ZA ONKOLOGIJU I RADIOLOGIJU SRBIJE
Serbia

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (2)

Midterm report of staff exchanges, expert visits to IORS and research proposals submitted

Research and administrative staff exchanges (IORS and BRFAA - in collaboration with IDIBAPS and NKI) Expert visits to IORS (BRFAA, IDIBAPS and NKI, one visit each)Remote virtual training on omics data analysis (BRFAA, IDIBAPS and NKI - expertise applied to IORS staff)Preparation and submission of research proposals with emphasis on MSCA doctoral networks and postdoctoral fellowships (BRFAA, IDIBAPS and NKI AVL - expertise applied to IORS staff)

Increased IORS human capacities for biobank management and oversight

1.4 Train IORS personnel for biobank management and oversight (IDIBAPS/HCB and NKI)

Demonstrators, pilots, prototypes (1)

Establishment of a Research Management office at IORS

Form a Research Management Office at IORS by training IORS staff in specific management procedures and protocols (IORS - with expert advice from BRFAA, IDIBAPS/HCB and NKI)Train IORS staff on pre- and post-grant project management activities

Publicaciones

Thesis and dissertations (1)

Ispitivanje prognostičkih i prediktivnih kliničkih i molekularnih markera u lečenju lokalno uznapredovalog karcinoma rektuma neoadjuvantnom radiohemioterapijom primenom volumnog rotacionog planiranja zračne terapije i simultanog integrisanog boost-a

Autores: Marinkovic Mladen
Publicado en: 2024
Editor: Faculty of Medicine, University of Belgrade

Peer reviewed articles (8)

Abstracts

Publicado en: Molecular Oncology, Edición 19, 2025, ISSN 1574-7891
Editor: Wiley
DOI: 10.1002/1878-0261.70070

Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy

Autores: Stanojevic A, Spasic J, Marinkovic M, Stojanovic-Rundic S, Jankovic R, Djuric A, Zoidakis J, Fijneman R.J.A, Castellvi-Bel S, Cavic M.
Publicado en: Frontier in Genetics, Edición 14, 2024, ISSN 1664-8021
Editor: Frontiers
DOI: 10.1101/2023.09.21.23295916

Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Autores: Marinkovic M, Stojanovic-Rundic S, Stanojevic A, Ostojic M, Gavrilovic D, Jankovic R, Maksimovic N, Stroggilos R, Zoidakis J, Castellví-Bel S, Fijneman RJA, Cavic M.
Publicado en: Frontier in Genetics, Edición 14, 2023, ISSN 1664-8021
Editor: Frontiers Media S.A.
DOI: 10.1101/2023.06.20.23291673

Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer

Autores: Vuletic A, Mirjacic Martinovic K, Spasic J.
Publicado en: Pharmaceutics, Edición 16(1):54, 2023, ISSN 1999-4923
Editor: MDPI (Basel, Switzerland)
DOI: 10.20944/preprints202311.1805.v1

Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction

Autores: Marinković, M.; Stojanović-Rundić, S.; Stanojevic, A.; Tomašević, A.; Janković, R.; Zoidakis, J.; Castellví-Bel, S.; Fijneman, R.J.; Čavić, M.; Radulović, M
Publicado en: Journal of Clinical Medicine, Edición 13(2):421, 2024, ISSN 2077-0383
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.20944/preprints202310.0560.v1

Data-Independent Acquisition Mass Spectrometry Analysis of FFPE Rectal Cancer Samples Offers In-Depth Proteomics Characterization of the Response to Neoadjuvant Chemoradiotherapy

Autores: Stanojevic A, Samiotaki M, Lygirou V, Marinkovic M, Nikolic V, Stojanovic-Rundic S, Jankovic R, Vlahou A, Panayotou G, Fijneman RJA, Castellví-Bel S, Zoidakis J, Cavic M
Publicado en: Int J Mol Sci, Edición 24(20), 2023, ISSN 1661-6596
Editor: MDPI (Basel, Switzerland)
DOI: 10.1101/2023.05.12.23289671

Precision public health perspective: Is genomic population screening a viable option for the early detection of risks for oncological diseases? Reflections from Serbia

Autores: Bosiljka Đikanović, Janko Janković, Milena Čavić
Publicado en: Srpski medicinski casopis Lekarske komore, Edición 6, 2025, ISSN 2737-971X
Editor: Centre for Evaluation in Education and Science (CEON/CEES)
DOI: 10.5937/smclk6-57145

Dose Escalation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Short-Term Efficacy and Toxicity of VMAT–SIB vs. 3D-CRT

Autores: Suzana Stojanovic-Rundic, Mladen Marinkovic, Aleksandra Stanojevic, Dusica Gavrilovic, Radmila Jankovic, Natasa Maksimovic, Aleksandar Tomasevic, Predrag Petrasinovic, Sandra Radenkovic, Milena Cavic
Publicado en: Medicina, Edición 61, 2025, ISSN 1648-9144
Editor: MDPI AG
DOI: 10.3390/MEDICINA61030483

Conference proceedings (5)

The Road from Human Sample Collections to the First Rectal Cancer Biobank at the Institute for Oncology and Radiology of Serbia

Autores: A. Djuric, M. Tanic, S. Bjelogrlic, S. StojanovicRundic, M. Marinkovic, A. Stanojevic, R. Fijenman, S. Castellví-Bel, J. Zoidakis, M. Cavic
Publicado en: Molecular Oncology, Edición 17 (Suppl. 1) (2023) 1–597. p464-465, 2023, ISSN 1574-7891
Editor: John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
DOI: 10.1002/1878-0261.13469

Cancer Research

Autores: Cavic M, Djuric A, Marinkovic M, Stanojevic A, Tanic M, Bjelogrlic S, Spasic J, Damjanovic A, Djordjic Crnogorac M, Vuletic A, Mirjacic Martinovic K, Radulovic M, Stojanovic-Rundic S, Krivokuca A, Jankovic R, Castellvi-Bel S, Zoidakis J, Fijneman R.
Publicado en: Cancer Research, Edición 84 (6_Supplement): 1304, 2024, ISSN 0008-5472
Editor: American Association for Cancer Research

Molecular Oncology

Autores: Djuric A, Radulovic M, Damjanovic A, Fijneman R, Castellvi-Bel S, Zoidakis J, Cavic M.
Publicado en: Molecular Oncology, Edición Vol. 18. Supp. 1, 2024, ISSN 1574-7891
Editor: Elsevier BV
DOI: 10.1002/1878-0261.13683

Molecular Oncology

Autores: Vuletic A, Mirjačić Martinović K, Srdić-Rajić T, Tišma Miletić N, Đurić A, Nikolić K, Ružić D, Čavić M.
Publicado en: Molecular Oncology, Edición 19 (S1), 2025, ISSN 1574-7891
Editor: Elsevier BV

Correlation between genetic and proteomic expression of predictive biomarkers of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer identified by DIA mass spectrometry

Autores: A. Stefanovic, V. Lygirou, S. Stojanović-Rundić, R. Janković, S. Castellvi-Bel, R. J.A. Fijneman, A. Vlahou, J. Zoidakis, M. Samiotaki, M. Čavić
Publicado en: Molecular Oncology, Edición 17 (Suppl. 1) (2023) 1–597. p96-97, 2023, ISSN 1574-7891
Editor: John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies
DOI: 10.1002/1878-0261.13469